Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution

ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.

Saved in:
Bibliographic Details
Main Authors: Oltulu,Refik, Satirtav,Gunhal, Donbaloglu,Meryem, Gunduz,Mehmet Kemal, Kerimoglu,Hurkan, Okka,Mehmet, Ozkagnici,Ahmet, Karaibrahimoglu,Adnan
Format: Digital revista
Language:English
Published: Conselho Brasileiro de Oftalmologia 2016
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0004-27492016000300147
record_format ojs
spelling oai:scielo:S0004-274920160003001472016-07-19Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solutionOltulu,RefikSatirtav,GunhalDonbaloglu,MeryemGunduz,Mehmet KemalKerimoglu,HurkanOkka,MehmetOzkagnici,AhmetKaraibrahimoglu,Adnan Cornea Collagen Cross-linking reagents Riboflavin/therapeutic use Ultraviolet rays Dextrans Visual acuity ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.info:eu-repo/semantics/openAccessConselho Brasileiro de OftalmologiaArquivos Brasileiros de Oftalmologia v.79 n.3 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147en10.5935/0004-2749.20160045
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Oltulu,Refik
Satirtav,Gunhal
Donbaloglu,Meryem
Gunduz,Mehmet Kemal
Kerimoglu,Hurkan
Okka,Mehmet
Ozkagnici,Ahmet
Karaibrahimoglu,Adnan
spellingShingle Oltulu,Refik
Satirtav,Gunhal
Donbaloglu,Meryem
Gunduz,Mehmet Kemal
Kerimoglu,Hurkan
Okka,Mehmet
Ozkagnici,Ahmet
Karaibrahimoglu,Adnan
Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
author_facet Oltulu,Refik
Satirtav,Gunhal
Donbaloglu,Meryem
Gunduz,Mehmet Kemal
Kerimoglu,Hurkan
Okka,Mehmet
Ozkagnici,Ahmet
Karaibrahimoglu,Adnan
author_sort Oltulu,Refik
title Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
title_short Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
title_full Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
title_fullStr Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
title_full_unstemmed Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
title_sort six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution
description ABSTRACT Purpose: To analyze the short-term clinical and topographic outcomes in patients with keratoconus after corneal collagen cross-linking treatment (CXL) with dextran-free isotonic riboflavin solution. Methods: In this retrospective case series, 26 eyes from 26 patients with keratoconus were studied. The best corrected visual acuity (BCVA) and refractive and topographic findings were analyzed at a 6-month follow-up. Results: The mean BCVA (Snellen lines) values before and 1, 3, and 6 months after CXL were 0.51 ± 0.2, 0.48 ± 0.2, 0.57 ± 0.2, and 0.64 ± 0.2, respectively, and the difference between the preoperative and 6-month values was statistically significant (p=0.006). The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. (p=0.145 and p=0.001, respectively). In addition, the maximum keratometry decreased progressively and significantly from the preoperative value during follow-up (p=0.003). The central and minimal corneal thicknesses, including those of the epithelium, also decreased from 442.8 ± 25.6 µm and 430.5 ± 23.9 µm preoperatively to 420.7 ± 31.8 µm and 409.3 ± 28.7 µm at the most recent follow-up (p<0.001), respectively. No intraoperative or postoperative complications were observed. Conclusions: CXL with dextran-free isotonic riboflavin solution appears to be a safe treatment alternative for keratoconus and yields sustained short-term improvements in visual acuity, keratometric readings, and corneal thickness. However, long-term results are needed to confirm these outcomes.
publisher Conselho Brasileiro de Oftalmologia
publishDate 2016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492016000300147
work_keys_str_mv AT oltulurefik sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT satirtavgunhal sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT donbaloglumeryem sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT gunduzmehmetkemal sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT kerimogluhurkan sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT okkamehmet sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT ozkagniciahmet sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
AT karaibrahimogluadnan sixmonthoutcomesofcornealcrosslinkingwithdextranfreeisotonicriboflavinsolution
_version_ 1756373219619635200